SCHEMBL763245

SCHEMBL763245

COCCCn1c([C@@H]2CCCN(C(=O)C[C@H](C)Cc3ccc(-c4ccc(C(=O)NCCOC)c(F)c4)cc3)C2)nc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 9/20 0.42
CYP2D6 P10635 7/20 0.42
KCNH2 Q12809 10/20 0.40
CHRM1 P11229 3/20 0.40
MAPK1 P28482 1/20 0.37
CHRM4 P08173 1/20 0.36
MCHR1 Q99705 1/20 0.36
CYP3A4 P08684 1/20 0.36
KDM4E B2RXH2 1/20 0.36
APAF1 O14727 1/20 0.36
USP2 O75604 1/20 0.36
NSD2 O96028 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762743 0.96 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL740423 0.93 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL740424 0.93 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL762928 0.93 HRH1 (0.44) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL742610 0.92 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL763242 0.90 HRH1 (0.42) HRH1CYP2D6KCNH2CHRM1
SCHEMBL740525 0.89 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL740524 0.89 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL10293052 0.89 HRH1 (0.39) HRH1CYP2D6KCNH2CHRM1MAPK1
SCHEMBL739437 0.88 HRH1 (0.40) HRH1CYP2D6KCNH2CHRM1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed